2010
DOI: 10.1200/jco.2010.28.15_suppl.e13120
|View full text |Cite
|
Sign up to set email alerts
|

The use of poly(ADP-ribose) polymerase (PARP1) inhibitors (AG14361, AZD2281, ABT888) in combination with capecitabine, 5-fluorouracil, or paclitaxel in the treatment of hereditary and sporadic breast and ovarian cancer.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles